Biotechnology

TauRx Reports First Phase 3 Results for LMTX(R)

ABERDEEN, Scotland and SINGAPORE, July 27, 2016 /PRNewswire/ -- * LMTX® as monotherapy demonstrates significant reductions in disease progression in mild and moderate Alzheimer's disease * Strong results in both cognitive and functional tests supported by brain scan evidence of slow-down in ...

2016-07-27 20:00 1465

Merck Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts

DARMSTADT, Germany, July 19, 2016 /PRNewswire/ -- Merck , a leading science and technology company, today announced plans to build a new campus inBurlington, Massachusetts that will serve as a major hub for the North American life science business of Merc...

2016-07-19 20:00 2243

Significant Growth Opportunities for Mass Spectrometry Vendors through Mergers and Acquisitions with Clinical Diagnostics Companies, notes Frost & Sullivan

SINGAPORE, July 19, 2016 /PRNewswire/ -- Innovations in mass spectrometry technologies, coupled with rising application in the life sciences and clinical analysis sectors, are creating rich opportunities for mergers and acquisitions in the global market. Mass spectrometry vendors will be keen to ...

2016-07-19 18:51 1495

Merck Relaunches Customer Collaboration Centers with New Concept and M Lab(TM) Name

DARMSTADT, Germany, July 18, 2016 /PRNewswire/ -- Merck , a leading science and technology company, is relaunching its global network of customer collaboration centers, providing customers a shared, exploratory environment with scientists and engineers wo...

2016-07-18 20:00 1812

Regenerative Medicine Research Attracts Substantial Public and Private Funding

LONDON, July 18, 2016 /PRNewswire/ -- Regenerative medicine is redefining medical technology synergies by combining stem cell technology with tissue engineering. Advanced biomaterials joint with small molecules and biologics allow to regenerate and restore functions of human tissues and organs...

2016-07-18 18:00 1060

LABORIE Announces Newly Redesigned Website Featuring Extensive Urology and Gastroenterology Products and Educational Offerings

TORONTO, July 15, 2016 /PRNewswire/ -- Laborie Medical Technologies ("LABORIE"), based inToronto, Canada, has redesigned its website to include Medical Measurement Systems (MMS) Urology and Gastroenterology products. The newly designed website (http://www.laborie.com ) no...

2016-07-15 20:30 2477

Regenerative Medicine Research Attracts Substantial Public and Private Funding

LONDON, July 15, 2016 /PRNewswire/ -- Regenerative medicine is redefining medical technology synergies by combining stem cell technology with tissue engineering. Advanced biomaterials joint with small molecules and biologics allow to regenerate and restore functions of human tissues and organs...

2016-07-15 19:27 1530

Sorrento and Servier Enter Into Exclusive Worldwide License and Collaboration Agreement for Development and Commercialization of Anti-PD-1 Antibody

An Immuno-Oncology Therapy with Many Potential Applications  SAN DIEGO, July 11, 2016 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer and other unmet medical needs, and Serv...

2016-07-11 21:00 1591

Agilent Technologies to Host Science and Technology Symposium in South East Asia

SINGAPORE, July 11, 2016 /PRNewswire/ -- Agilent Technologies (NYSE:A) today announced it will be hosting its 2016 Science and Technology Symposium series in South East Asia. The series is set to bring scientific communities and Agilent experts together in a unique opportunity to discuss the lates...

2016-07-11 09:00 2430

Laborie Completes Strategic Investment In Medi-Tate Ltd.

TORONTO, July 7, 2016 /PRNewswire/ -- Laborie Medical Technologies ("LABORIE"), based inToronto, Canada, has completed an investment in Medi-Tate Ltd. Medi-Tate, headquartered in Akiva,Israel, is an Israeli medical device company focused on research, development, manufacture and sale of innovativ...

2016-07-07 20:30 2006

Aptuit LLC and Dimension Therapeutics Enter Strategic Partnership to Advance Select Dimension Programs Toward IND Filing

GREENWICH, Conn. and CAMBRIDGE, Mass., July 7, 2016 /PRNewswire/ -- Aptuit LLC, a premier global drug discovery and development CRO, and Dimension Therapeutics, a biopharmaceutical company advancing novel, adeno-associated virus (AAV) gene therapies targeting the liver, a key organ for human met...

2016-07-07 20:23 2559

LEO Pharma Enters Biologics Through Strategic Partnership With AstraZeneca

BALLERUP, Denmark, July 1, 2016 /PRNewswire/ -- LEO Pharma is a significant step closer to realising its vision of becoming the preferred dermatology care partner following a strategic partnership with AstraZeneca announced today. (Logo: http://photos.prnewswire.com/prnh/20130221/595427

2016-07-01 15:38 1990

Merck to Develop Next-Generation Purification Processes with International Vaccine Institute

DARMSTADT, Germany, June 28, 2016 /PRNewswire/ -- Merck , a leading science and technology company, has entered a research agreement with theInternational Vaccine Institute (IVI) of Seoul, South Korea to help develop ...

2016-06-28 20:00 1925

AAHRPP Accredits Four More Research Organizations, Including First in Africa, South America

WASHINGTON, June 27, 2016 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs today announced that it has accredited four more research organizations, including its first organizations inAfrica and South America. Logo - http://photos.prnewswire.com/prnh/20...

2016-06-27 22:00 1558

3 Israeli Startups - Boomerang, NiNiSpeech & AerialGuard - Chosen to Represent Israel at Shengjing Global Innovation Awards 2016 in Beijing, Competing Against Startups From U.S., Europe, and China for Prizes Worth $1.5 Million

JERUSALEM, June 27, 2016 /PRNewswire/ -- The three Israeli startups chosen to representIsrael at the finals of the Shengjing Global Innovation Awards 2016 in Beijing this August are genetic-therapy-for-cancer-developer Boomerang, mobile speech therapy startup NiNiSpeech and creator of autonomous ...

2016-06-27 10:24 2355

Life Science Disruptive Technologies and Emerging Trends Spur Growth Opportunities throughout the Industry

MOUNTAIN VIEW, California, June 23, 2016 /PRNewswire/ -- WHEN: 9:00 a.m. CST on Thursday, July 7, 2016 LOCATION: Online, with free registration (Email kayla.belcher@frost.com ) EXPERT PANELISTS:  Frost & Sullivan's Global Vice President of Life Sciences, Nit...

2016-06-23 21:35 1826

Frontier Biotech Reports Primary Endpoint Met in Phase 2 Trial of AB001 In Chronic Low Back Pain

NANJING, China, June 22, 2016 /PRNewswire/ -- Frontier Biotechnologies Inc. today reported that a Phase 2 clinical trial for its novel patch product AB001 met primary endpoint at week-2, demonstrating statistically significant (p=0.023) and clinically meaningful pain relief against placebo. Condu...

2016-06-22 16:02 1974

Cathay Industrial Biotech Ltd. Announces Ground-breaking and Agreement Signing for Significant Expansion in Bio-produced Monomer and Polyamide Production

SHANGHAI, June 22, 2016 /PRNewswire/ -- Cathay Industrial Biotech Ltd. (Cathay), a leading privately-held industrial biotechnology company focused on producing specialty bio-based chemicals, announced a ground-breaking and agreement signing to initiate a significant expansion in their production ...

2016-06-22 14:18 2533

Terumo BCT Announces a $17.4 Million Funding Contract from the Biomedical Advanced Research and Development Authority (BARDA)

LAKEWOOD, Colorado, June 22, 2016 /PRNewswire/ -- Terumo BCT, a global medical device manufacturing company, is pleased to announce that it has been awarded $17.4 million in initial funding from the Biomedical Advanced Research and Development Authority (BARDA) to initiate a clinical trial using t...

2016-06-22 03:48 2183

Scarcity of Mass Production Infrastructure Threatens Growth Opportunities in Cell-based Therapies

MOUNTAIN VIEW, Calif., June 21, 2016 /PRNewswire/ -- The fast-growing cell therapy market is attracting government and private funds, positioning disruption throughout the pharmaceutical landscape.Stem cell therapy, the largest segment, has an impressive number of clinical trials worldwide. Fu...

2016-06-21 21:35 1651
1 ... 65666768697071 ... 73